middle.news
Clinuvel opens European pathway for NEURACTHEL Instant
8:30am on Friday 30th of October, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Clinuvel opens European pathway for NEURACTHEL Instant
8:30am on Friday 30th of October, 2026 AEDT
Key Points
Marketing authorisation dossier filed for NEURACTHEL Instant
Three initial EU member states selected as launch markets
Decentralised procedure expected to run for 300 days excluding clock stops
Validation and initial formal feedback expected in about four months
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE